Antigen Presenting Equipment & Supplies
19 equipment items found
Manufactured by:SD Biosensor based inSuwon-si, SOUTH KOREA
STANDARD Q COVID-19 Ag Home Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigen present in human nasal ...
Manufactured by:Khloris Biosciences, Inc. based inMountain View, CALIFORNIA (USA)
iPSC vaccination presents a differentiated approach to cancer treatment, targeting a panoply of antigens, leveraging the patient's immune system for optimized antigen presentation, and engaging both cellular and humoral ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
The Antigen Rapid Test assay from the Gold Standard Diagnostics Group is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid (N) Protein antigens present in respiratory ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Sotigalimab, a CD40 agonistic monoclonal antibody. Sotigalimab binds CD40 with high affinity and activates antigen-presenting cells, thereby stimulating cancer-specific T cell responses. Sotigalimab is mainly used in the study of metastatic pancreatic cancer and metastatic ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
The GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab) is a single-use test kit intended to detect the presence of the SARS-CoV-2 virus, with self-collected nasal swab specimen from symptomatic individuals who are suspected of being infected with COVID-19. A positive result indicates SARS-CoV-2 antigens present in the ...
Manufactured by:Shenzhen Landwind Medical Co., Ltd based inShenzhen, CHINA
When the human body contacts with foreign antigens, the first antibody produced is IgM, which is secreted directly by the receptor on the surface of B cells. The B cells that produce IgM enter the lymph nodes, receive stimulation from T cells and antigen-presenting cells in the center of occurrence, further mature, differentiate into plasma ...
Manufactured by:EirGenix, Inc based inNew Taipei City, TAIWAN
CRM197 has been tested in animals studies and it has been demonstrated to lack toxicity. CRM197 can be used as a carrier protein for vaccine delivery. It acts by helping polysaccharide antigens to bind on and be internalized into antigen-presenting cells. This in turn induces T-cell-dependent responses. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Mitazalimab (ADC-1013; JNJ-64457107) is FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells. Therefore, Mitazalimab induces tumor-specific T cells to infiltrate and kill tumors. Mitazalimab remodels the tumor-infiltrating myeloid ...
Manufactured by:Episkin based inLyon Cedex 7, FRANCE
The SkinEthic RHE-LC model is a standard epidermal model in which Langerhans cells progenitors have been integrated. During the tissue reconstruction, these immature cells have differentiated into antigen-presenting Langerhans cells expressing the specific marker CD207 (langerin). They are mostly located and evenly spread within the supra-basal epidermal layer. ...
Manufactured by:T-Cure BioScience, Inc. based inSherman Oaks, CALIFORNIA (USA)
Our exclusive iSORT (Isolation of Optimal Reverse Immunology Generated TCR) platform is able to isolate TCRs against unique selected tumor-associated intracellular and extracellular antigens and neoantigens in the context of an HLA molecule, allowing us to focus on specific cancers and patient populations based on their genetic makeups. Using this technology, we are able to ...
Manufactured by:Actym Therapeutics based inBerkeley, CALIFORNIA (USA)
In preclinical studies, STACT specifically enriches in many types of solid tumors and not in healthy tissue. Once there, STACT delivers multiplexed immuno-modulatory payloads directly to tumor-resident antigen-presenting cells. ...
Manufactured by:BriaCell Therapeutics Corp. based inWest Vancouver, BRITISH COLUMBIA (CANADA)
We believe that Bria-IMT™/Bria-OTS™, activates the patient’s immune system to recognize tumor cells and destroy them. We hypothesize that Bria-IMT™/Bria-OTS™, exert their action by stimulating the antigen-presentation system (i.e. the system that presents antigen material on the surface of the tumor ...
by:Ionpath, Inc. based inMenlo Park, CALIFORNIA (USA)
Integrins mediate myeloid cell recruitment from the blood vessels into tissue and lymph nodes and contribute to the immunological synapse between T cells and antigen presenting ...
Manufactured by:Fate Therapeutics, Inc. based inSan Diego, CALIFORNIA (USA)
Resistance to checkpoint inhibitor therapy has been linked to impaired immune cell infiltration into the tumor, impaired cytokine response, and deficiencies in antigen presentation including altered expression of major histocompatibility (MHC) class I complex. As a result, there is significant unmet need for novel therapeutic approaches to overcome resistance to ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
CLEC-1 antagonist monoclonal antibodies have been identified as an innovative cancer immunotherapy that releases the brakes on macrophage phagocytosis and dendritic cells’ antigen presentation and demonstrates synergistic anti-cancer effects, in particular when paired with ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
ML-T7 blocks Tim-3 interactions with PtdSer and CEACAM1.ML-T7 not only enhances the antitumor activity of adoptive transfer therapy with cytotoxic T lymphocytes (CTLs) and CAR T cells but also increases the effector function of T cell. ML-T7 promotes NK cells’ killing activity against tumor cells and DC antigen-presenting capacity. ML-T7 directly exerts antitumor ...
Manufactured by:Greenwich LifeSciences, Inc. based inHouston, TEXAS (USA)
GP2 is administered in combination with GM-CSF, an FDA-approved immunoadjuvant, which stimulates the proliferation of antigen presenting ...
Manufactured by:Triplex International Biosciences (China) Co., Ltd, based inXiamen, CHINA
The Dengue NS1 Antigen Rapid Test Kit is designed primarily for rapid in vitro qualitative assessment of the Dengue NS1 antigen present in human serum, plasma, and whole blood samples collected via venipuncture or fingerstick. This product is strictly intended for professional in vitro diagnostic use, assisting healthcare professionals in the ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
VAC2, which is produced from our pluripotent cell technology using a directed differentiation method, is comprised of a population of mature dendritic cells. As the most potent type of antigen presenting cell in the body, dendritic cells instruct our body’s immune system to attack and eliminate harmful pathogens and unwanted cells. To target cancerous ...